Pashna Munshi, MD

Articles

Current Treatment Options for Patients with Steroid-Refractory Acute GVHD

May 4th 2023

Closing her discussion, Dr Pashna Munshi reviews recent data on the available treatment options for patients with steroid-refractory acute GVHD.

Available Frontline Treatment Options for Patients With Acute GVHD

April 27th 2023

Pashna Munshi, MD, discusses how acute GVHD is staged and graded, and the common frontline treatment options.

Comparing Acute and Chronic GVHD

April 27th 2023

Pashna Munshi, MD, reviews the differences between acute and chronic GVHD.

Currently Available Options for GVHD Prophylaxis

April 13th 2023

Dr Pashna Munshi explains the currently available options for GVHD prophylaxis and which regimens she utilizes the most in her clinical practice.

Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant

April 13th 2023

Pashna Munshi, MD, details how age and risk factors into her choice of conditioning regimen for patients with GVHD receiving allogeneic transplant.

Indications for Allogeneic Stem Cell Transplantation in the Treatment of Myeloid Malignancies

April 13th 2023

Dr Pashna Munshi describes for what myeloid malignancies allogeneic transplantation is indicated, and its curative potential.

Patient Profile Presentation: A 44-Year-Old Woman With Acute Myeloid Leukemia and Graft-Versus-Host Disease (GVHD)

April 13th 2023

Pashna Munshi, MD, presents the patient profile of a 44-year-old woman with acute myeloid leukemia diagnosed with grade 2 skin acute GVHD, and shares her initial impressions and what she might have done differently.